Fig. 1From: Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysisChanges in TSH and FT4 levels in this case. Roxadustat was administered from February 2 to June 12, 2020. Reference ranges of TSH and FT4 were between 0.541 and 4.261 µIU/mL and between 0.76 and 1.65 ng/dL, respectively. Abbreviations: TSH, thyroid stimulating hormone; FT4, free thyroxine; MRI, magnetic resonance imagingBack to article page